ImmunXperts
ImmunXperts, now part of IQVIA's Discovery Sciences division, is a Belgian in vitro immunology CRO providing immunogenicity risk assessment, T-cell and cytokine release assays, MAPPS, and PBMC biobank services to pharmaceutical and biotech clients developing biologics, cell therapies, and immuno-oncology products.
- Company typePrivate
- Founded2014
- HeadquartersGosselies, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ImmunXperts does
ImmunXperts is a Belgian specialty contract research organization headquartered in Gosselies, Belgium, founded in 2014, that provides in vitro immunology testing services to pharmaceutical and biotechnology companies developing biologics, monoclonal and bispecific antibodies, cell and gene therapy products, novel anti-oncolytic molecules, small molecules, and generic peptides. The lab's core portfolio centers on immunogenicity risk assessment — the prediction and characterization of anti-drug antibody responses — using T-cell activation and proliferation as surrogate markers, cytokine release assays, and MHC-associated peptide proteomics (MAPPS), alongside functional screening of immuno-oncology and cell/gene therapy candidates. The company also maintains a PBMC biobank of more than 1,300 healthy donors with 4-digit HLA typing under a Belgian Biobank License, enabling population-diverse clinical trial simulation; consultative protocol review, theoretical immunology courses, and hands-on training are offered as adjacent service lines.
ImmunXperts firmographics
Firmographics- Name
- ImmunXperts
- Legal name
- ImmunXperts
- Website
- https://immunxperts.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- ImmunXperts, now part of IQVIA's Discovery Sciences division, is a Belgian in vitro immunology CRO providing immunogenicity risk assessment, T-cell and cytokine release assays, MAPPS, and PBMC biobank services to pharmaceutical and biotech clients developing biologics, cell therapies, and immuno-oncology products.
- Ownership category
- akta.pro rank
ImmunXperts industry classification
Industry- Product category
- Preclinical Immunology Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215), Testing Laboratories and Services (541380)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Immunotoxicology & Immunogenicity Assessment (HLAGAFAH)
- akta.pro secondary industries
- Immuno-Oncology & Immune Monitoring Biomarkers (TMB, MSI, MRD, immune profiling) (HLAAAMAK), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
Keywords
Where ImmunXperts is headquartered
LocationHeadquarters
- HQ city
- Gosselies
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
ImmunXperts business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Laboratory Testing Services: Contract laboratory services providing immunogenicity risk assessment and functional screening assays for biopharmaceutical clients. Revenue derived from testing fees for discovery through pre-IND stage programs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
ImmunXperts product offering
Product offeringCore offering
ImmunXperts provides contract in vitro immunology testing services focused on immunogenicity risk assessment and immuno-oncology, including T-cell activation and proliferation assays, cytokine release assays, and MHC-associated peptide proteomics (MAPPS). The Gosselies, Belgium-based lab operates a Belgian-licensed PBMC biobank with samples from more than 1,300 healthy donors with 4-digit HLA typing, and supports pharmaceutical and biotech clients developing biologics, monoclonal antibodies, bispecific antibodies, cell and gene therapies, and novel anti-oncolytic molecules from discovery through pre-IND stages.
Product overview
IQVIA's In Vitro Immunology laboratory (formerly ImmunXperts) is a specialized contract research organization providing immunogenicity risk assessment and functional screening services for biotherapeutics. The offering is organized around a core portfolio of laboratory services including T-cell activation assays, cytokine release assays, and MAPPS (MHC-associated peptide proteomics), supplemented by a high-quality PBMC biobank with over 1300 donors and consultative training services. Located in Gosselies, Belgium, the lab assists clients in advancing programs from discovery through pre-IND and exploratory clinical stages.
Differentiator
Problem solved
Functional benefit
Products and services
- Immunogenicity Risk Assessment Services Contract laboratory service that uses in silico and in vitro methods to evaluate the potential for anti-drug antibody formation in biologic and novel therapeutic candidates, intended for pharmaceutical and biotech sponsors.
- T-cell Activation and Proliferation Assays In vitro assays using T-cell activation and proliferation as surrogate markers for the induction of anti-drug antibodies, providing functional insights into immune-mediated adverse events for biotherapeutic developers.
- Cytokine Release Assays In vitro assays that assess cytokine release as a measure of immune activation and potential adverse events for drug candidates in development.
- MHC-associated Peptide Proteomics (MAPPS) Proteomics service identifying and characterizing peptide fragments presented by major histocompatibility complex molecules to support immunogenicity evaluation of biotherapeutics.
- Functional Screening Assays for Immuno-oncology Functional screening assays for drug candidates in immuno-oncology, cell and gene therapy, and other disease areas, supporting developers of novel therapeutics.
- PBMC Biobank Services Storage and provision of high-quality PBMC samples from more than 1,300 healthy donors with 4-digit HLA typing under a Belgian Biobank License, supporting diverse population representation for clinical trial simulation and immunology studies.
- Antibody and New Modality Services Immunogenicity and functional testing services supporting novel anti-oncolytic molecules, monoclonal antibodies, bispecific antibodies, new antibody formats, small molecules, and generic peptides.
Companies that use ImmunXperts
Customer profileSegments2 records
Ideal customer profiles2 records
ImmunXperts technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ImmunXperts partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IQVIAcoreImmunXperts was acquired and integrated into IQVIA's Discovery Sciences division as their In Vitro Immunology lab team. The team now operates under IQVIA's corporate structure while maintaining specialized immunology testing capabilities. This represents a significant integration where ImmunXperts' expertise became part of IQVIA's broader laboratory services offering.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
ImmunXperts competitors and assessment
Company assessmentBroad incumbents
- Lonza: Provides cell and gene therapy manufacturing services alongside bioassay and immunogenicity testing for biologics developers. Comparable in supporting novel-modality immunology workflows, with a much larger biologics manufacturing footprint.
- Eurofins Scientific: Bioanalytical testing network with extensive immunology, immunogenicity, and biomarker assay capabilities across pharma services. Comparable as a scaled alternative for the same biopharma buyer set ImmunXperts serves.
- Labcorp Drug Development (Fortrea): Global CRO offering immunogenicity, bioanalytical, and central lab services for biologics and cell/gene therapy programs. Comparable in service scope to ImmunXperts, with substantially broader geographic footprint and program capacity.
- WuXi AppTec (WuXi Biologics / WuXi STA): Global CRO/CDMO offering biologics discovery, immunology, and bioassay services. Comparable in offering immunogenicity and cell-based functional assays, with significantly broader China-based capacity.
- Charles River Laboratories: Large preclinical CRO with broad immunogenicity, bioanalytical, and cell-based assay services across the discovery-to-IND continuum. Directly comparable to ImmunXperts' in vitro immunology offering, but at much greater scale and as part of a wider safety/CMO portfolio.
Others
- Sartorius: Supplies bioprocessing and cell-line engineering tools used by biologics and cell-therapy developers, with adjacent analytical and cell-based assay capabilities. Comparable as an adjacent ecosystem participant that cell/gene therapy customers of ImmunXperts also engage.
Emerging players
- CellGenix: Supplier of raw materials and testing/QC services for cell and gene therapy developers. Comparable in serving cell/gene therapy customers that require immunology-relevant characterization, with focused cell-therapy expertise.
- ReachBio Research Labs: Specialized cell-based assay CRO offering functional immunology, cytokine, and hematopoietic assays for pharma research. Comparable niche overlap with ImmunXperts' functional screening offerings, at a smaller, emerging-player scale.
Direct peers
- ProImmune: Specialized provider of MHC-associated peptide proteomics (MAPPS), immunogenicity, and immune-monitoring services. Most directly comparable peer to ImmunXperts on MAPPS and T-cell assay offerings, both serving biopharma R&D.
- Abzena: Contract development organization focused on biologics and antibody-drug conjugates, including immunogenicity and bioassay services. Comparable in serving biologic developers needing immunogenicity risk assessment, with broader antibody development capability.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ImmunXperts social profiles
Digital presenceImmunXperts compliance and trust
Trust signalCompliance1 record
ImmunXperts financial estimates
Financial estimateRevenue estimate
Valuation estimate
ImmunXperts leadership team
Management profileNumber of profiles
Profiles1 record
ImmunXperts funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ImmunXperts M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ImmunXperts
What does ImmunXperts do?
ImmunXperts provides contract in vitro immunology testing services focused on immunogenicity risk assessment and immuno-oncology, including T-cell activation and proliferation assays, cytokine release assays, and MHC-associated peptide proteomics (MAPPS). The Gosselies, Belgium-based lab operates a Belgian-licensed PBMC biobank with samples from more than 1,300 healthy donors with 4-digit HLA typing, and supports pharmaceutical and biotech clients developing biologics, monoclonal antibodies, bispecific antibodies, cell and gene therapies, and novel anti-oncolytic molecules from discovery through pre-IND stages.
When was ImmunXperts founded?
ImmunXperts was founded in 2014. It employs 11 to 50 people.
Where is ImmunXperts based?
ImmunXperts is headquartered in Gosselies, Belgium, in the Europe region.
How does ImmunXperts make money?
One revenue line is on record: laboratory Testing Services.
Who are ImmunXperts's main competitors?
Broad incumbents on record are Lonza, Eurofins Scientific, Labcorp Drug Development (Fortrea), WuXi AppTec (WuXi Biologics / WuXi STA) and Charles River Laboratories. Sartorius is listed as an others. Emerging players are CellGenix and ReachBio Research Labs. Direct peers are ProImmune and Abzena.
Does ImmunXperts have an API?
No public API is recorded for ImmunXperts.
What industry is ImmunXperts in?
ImmunXperts's product category is Preclinical Immunology Laboratory Services. Its primary akta.pro industry code is HLAGAFAH, Immunotoxicology & Immunogenicity Assessment, with a secondary code of HLAAAMAK, Immuno-Oncology & Immune Monitoring Biomarkers (TMB, MSI, MRD, immune profiling). Its NAICS code is 621511 and its SIC code is 8731.